GALANTAMINE SZ galantamine (as hydrobromide) 24mg modified release capsules blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

galantamine hydrobromide, Quantity: 30.756 mg (Equivalent: galantamine, Qty 24 mg)

Available from:

Southern Cross Pharma Pty Ltd

INN (International Name):

Galantamine hydrobromide

Pharmaceutical form:

Capsule, modified release

Composition:

Excipient Ingredients: iron oxide yellow; hypromellose; magnesium stearate; titanium dioxide; microcrystalline cellulose; iron oxide red; Gelatin; ethylcellulose; erythrosine; indigo carmine

Administration route:

Oral

Units in package:

28

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type

Product summary:

Visual Identification: opaque orange-orange size 2 hard gelatin capsule containing three round biconvex tablets; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2012-01-20